logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
A

Ayalew Tefferi

mayo clinic

152H-index
2.1KPaper Count
10.3WCitation Count
Published Papers 727
Publication Date
logo
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia
errBlood Cancer Journal
IF11.6
err2026-08-17
err0
errOAAI
errMahnoor Fatima; Sudhesh Kumar; Momna Warraich; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
errShare
errSave
Treatment of adult acute lymphoblastic leukemia—a therapeutic revolution in the making
errBlood Cancer Journal
IF11.6
err2026-08-05
err0
errOAAI
errHagop Kantarjian; Ayalew Tefferi
errShare
errSave
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients
errAmerican Journal of Hematology
IF9.9
err2026-07-28
err0
PREAI
errAli Alsugair; Saubia Fathima; Mohammad M. Alhousani; Estefania Gauto Mariotti; Abiola Bolarinwa; Priyansh Faldu; Muhammad Yousuf; Clifford M. Csizmar; James Foran; Abishek A. Mangaonkar; Mark Litzow; Hemant Murthy; Lisa Sproat; Jeanne Palmer; Aasiya Matin; Ernesto Ayala; James Slack; Luis Porrata; Madiha Iqbal; Nandita Khera; Nathan Punwani; Saad Kenderian; Saurabh Chhabra; Kebede H. Begna; Animesh Pardanani; William J. Hogan; Mithun Vinod Shah; Hassan B. Alkhateeb; Naseema Gangat; Mrinal Patnaik; Ayalew Tefferi
errShare
errSave
Selinexor for myelofibrosis or a drug in search of a disease?
errBlood Cancer Journal
IF11.6
err2026-07-25
err0
errOAAI
errNaseema Gangat; Ayalew Tefferi
errShare
errSave
Arterial thrombosis and cancer: insights from observations in myeloproliferative neoplasms and CHIP
errBlood Cancer Journal
IF11.6
err2026-07-17
err0
errOAAI
errTiziano Barbui; Alessandro Maria Vannucchi; Ayalew Tefferi
errShare
errSave
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia
errBlood Cancer Journal
IF11.6
err2026-07-11
err0
errOAAI
errGiuseppe G. Loscocco; Fnu Aperna; Moazah Iftikhar; Priyansh Faldu; Masooma S. Rana; Amritpal Singh; Tiziano Barbui; Paola Guglielmelli; Alessandro M. Vannucchi; Animesh Pardanani; Naseema Gangat; Ayalew Tefferi
errShare
errSave
ICC/WHO-Defined and NGS-Annotated Idiopathic Hypereosinophilia (iHES/iHE): Mutations, Clinical and Treatment Details, and Predictors of Survival
errAmerican Journal of Hematology
IF9.9
err2026-06-19
err0
errOAAI
errShraddha P. Patel; Muhammad Yousuf; Rania Abdelaziz; Priyansh Faldu; Shivani P. Udyawar; Aysel Kaplan Bayraktar; Abiola B. Bolarinwa; Cinthya J. Zepeda Mendoza; Kaaren K. Reichard; David S. Viswanatha; Rong He; Naseema Gangat; Animesh Pardanani; Ayalew Tefferi
errShare
errSave
Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”?
errAmerican Journal of Hematology
IF9.9
err2026-06-07
err0
errOAAI
errSudhir Tauro; Ayalew Tefferi
errShare
errSave
Distinct Longitudinal Patterns of Basal and Squamous Cell Carcinoma in Polycythemia Vera and Essential Thrombocythemia
errAmerican Journal of Hematology
IF9.9
err2026-05-29
err0
errOAAI
errGiuseppe G. Loscocco; Naseema Gangat; Paola Guglielmelli; Animesh Pardanani; Alessandro M. Vannucchi; Ayalew Tefferi
errShare
errSave
Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities
errAmerican Journal of Hematology
IF9.9
err2026-04-17
err0
errOAAI
errGiuseppe G. Loscocco; Fnu Aperna; Moazah Iftikhar; Priyansh Faldu; Masooma S. Rana; Animesh Pardanani; Paola Guglielmelli; Alessandro M. Vannucchi; Naseema Gangat; Ayalew Tefferi
errShare
errSave
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia
errBlood Cancer Journal
IF11.6
err2026-04-12
err0
errOAAI
errSaubia Fathima; Lior Rokach; Muhammad Yousuf; Priyansh Faldu; Ali Alsugair; Clifford Csizmar; Merry Nakhleh; Abhishek A. Mangaonkar; Animesh Pardanani; Luca Lanino; Alessia Campagna; Giulia Maggioni; Noushin Farnoud; Raajit Rampal; Kaaren K. Reichard; Rong He; Naseema Gangat; Mrinal M. Patnaik; Matteo G. Della Porta; Ayalew Tefferi
errShare
errSave
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients
errBlood Cancer Journal
IF11.6
err2026-04-06
err0
errOAAI
errSaubia Fathima; Lior Rokach; Nour Ghosoun; Mahsa Rezasoltani; Rimal Ilyas; Ali Alsugair; Kristen McCullough; Maymona Abdelmagid; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek A. Mangaonkar; Aasiya Matin; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Mark R. Litzow; William Hogan; Mithun Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; Hemant Murthy; James Foran; Jeanne Palmer; Nathan Punwani; Lisa Sproat; Nandita Khera; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
errShare
errSave
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol
errBlood Cancer Journal
IF11.6
err2026-04-04
err0
errOAAI
errMuhammad Yousuf; Saubia Fathima; Ali Khalid A. Alsugair; Samuel J. Wu; Maymona G. Abdelmagid; Shraddha P. Patel; Priyansh C. Faldu; Rania M. Abdelaziz; Clifford M. Csizmar; Abhishek A. Mangaonkar; Cinthya J. Zepeda Mendoza; Kaaren K. Reichard; David S. Viswanatha; Rong He; Animesh Pardanani; Naseema Gangat; Mrinal S. Patnaik; Ayalew Tefferi
errShare
errSave
Clinical Experience With Venetoclax-Based Combinations for Relapsed/Refractory or MRD-Positive NPM1-Mutated Acute Myeloid Leukemia
errAmerican Journal of Hematology
IF9.9
err2026-04-01
err0
errOAAI
errMatteo Piccini; Naseema Gangat; Francesco Mannelli; Barbara Scappini; Gaia Ciolli; Francesca Crupi; Andrea Pasquini; Jessica Caroprese; Giorgio Cannetti; Chiara Lucarelli; Silvia Querceto; Giada Rotunno; Fabiana Pancani; Niccolò Bartalucci; Paola Guglielmelli; Ayalew Tefferi; Alessandro Maria Vannucchi
errShare
errSave
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent
errAmerican Journal of Hematology
IF9.9
err2026-02-18
err0
errOAAI
errNaseema Gangat; Momna Warraich; Sudhesh Kumar; Mahnoor Fatima; Kristen McCullough; Kebede H. Begna; Aref Al-Kali; Mrinal M. Patnaik; William J. Hogan; Abhishek Mangaonkar; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Hassan Alkhateeb; Mithun V. Shah; James M. Foran; Talha Badar; Jeanne M. Palmer; Cecilia Arana Yi; Animesh Pardanani; Ayalew Tefferi
errShare
errSave
NFκB/IL-6/JAK2/STAT axis in myelofibrosis is a key vulnerability that is targetable and relevant to JAK2 inhibitor treatment resistance
errBlood Cancer Journal
IF11.6
err2026-01-12
err0
errOAAI
errHuiqin Bian; Naseema Gangat; Na Shen; Jiuxia Pang; David Wald; William Tse; Ayalew Tefferi; Fei Yan; Shujun Liu
errShare
errSave
Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome
errBlood Cancer Journal
IF11.6
err2026-01-05
err0
errOAAI
errYassin A. Bashir; Ahmed A. Abdelrheem; Maymona Abdelmagid; Kaaren K. Reichard; Rong He; Cinthya J. Zepeda Mendoza; Animesh Pardanani; Naseema Gangat; Ayalew Tefferi
errShare
errSave
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study
errCancer
IF5.1
err2026-01-01
err0
errOAAI
errYasin, Irfan; Stengel, Anna; Shao, Haipeng; Kaur, Amandeep; Mason, Emily F.; Patwardhan, Pranav P.; Bailey, Nathanael G.; Ghosh, Sharmila; Inamdar, Kedar V.; Patel, Anand A.; Pandiri, Madhavi; Zhang, Jingjing; Sojitra, Payal; Tariq, Hamza; Pan, Zenggang; Wiredja, Danica; Wang, Peng; Tjota, Melissa Y.; Segal, Jeremy P.; Chang, Hong; Sallman, David A.; Arber, Daniel A.; Tefferi, Ayalew; Badar, Talha; Perry, Anamarija M.; Haferlach, Claudia; Lager, Angela M.; Venkataraman, Girish
errShare
errSave
CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends
errHAEMATOLOGICA
IF7.9
err2025-12-01
err1
errOAAI
errBolarinwa, Abiola; Szuber, Natasha; He, Rong; Pardanani, Animesh; Gangat, Naseema; Tefferi, Ayalew
errShare
errSave
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis
errBlood Cancer Journal
IF11.6
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
H
Hagop M. Kantarjian
H-index: 230 · Papers: 5.5K
J
Jörge E. Cortes
H-index: 179 · Papers: 3.6K
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
M
Michael J. Ackerman
H-index: 154 · Papers: 1.4K
G
Guillermo Garcia‐Manero
H-index: 149 · Papers: 2.9K
View more